Ledger.Open graph →
SEC Form D · filed August 3, 2017

Kezar Life Sciences, Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Jean-Pierre J. Sommadossi · South San Francisco, CADirectorGerald J. Chan · South San Francisco, CADirectorMichael J. Kauffman · South San Francisco, CADirectorJohn F. Fowler · South San Francisco, CAExec · DirectorFranklin J. Berger · South San Francisco, CADirectorChristopher J. Kirk · South San Francisco, CAExec · DirectorBihua J. Chen · San San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗